Indiana University Research & Technology Corporation
发明人:
Pili, Roberto
申请号：
AU2017211383
公开号：
AU2017211383A1
申请日:
2017.01.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Compositions including combinations of class I histone deacetylase (HDAC) inhibitors and programmed cell death protein 1 (PD-1) inhibitors for enhancing antitumor activity are disclosed. Further disclosed are methods of administering these compositions as immunotherapies for suppressing regulatory T cells in renal cell carcinoma.
